ICU Fluid Utilization Survey in Southeast Asia
Launched by CHULALONGKORN UNIVERSITY · Sep 6, 2023
Trial Information
Current as of September 06, 2025
Recruiting
Keywords
ClinConnect Summary
The ICU Fluid Utilization Survey in Southeast Asia is a clinical trial aimed at understanding how different types of fluids are used to treat critically ill patients in intensive care units (ICUs). The study focuses on three groups of patients: those who need extra fluids but are not bleeding or infected, patients who are bleeding but not infected, and patients who are infected. By gathering information through a short online survey from doctors working in Southeast Asia, the researchers hope to learn more about how fluids are managed in these critical situations.
To participate in this study, doctors must specialize in fields like anesthesiology, surgery, or critical care medicine, and they need to work in hospitals within Southeast Asia that have surgical or medical ICUs. The trial is currently recruiting participants, and it is open to physicians who meet these criteria. By sharing their experiences, participating doctors will contribute valuable insights that could improve patient care in ICUs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Specialty must be in Anesthesiology, Surgery, Critical Care Medicine, Pulmonology, Nephrology, Internal Medicine, General Practitioner
- • 2. Practice must be in Southeast Asia hospitals
- • 3. Must work in Surgical ICU, Medical ICU , and/or Mixed ICU
- Exclusion Criteria:
- • 1.Physicians who worked in cardiac, neurology or pediatric ICUs
About Chulalongkorn University
Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Trial Officials
Nattachai Srisawat, MD
Principal Investigator
Chulalongkorn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported